It is noteworthy that the treated animals also presented downregulation of CD11b and CD62L on synovial fluid Ly6G+ cells as well as increased activity of TrxR (which has been correlated with disease risk in patients with RA), in comparison with controls [122,123]. The gene discussed is ITGAM; the disease is rheumatoid arthritis.